Healthcare - Biotechnology - NASDAQ - CH
$ 8.06
-1.71 %
$ 12.7 M
Market Cap
-0.42
P/E
INCOME STATEMENT
1.61 M
REVENUE
-10.3 M
OPERATING INCOME
-10.6 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Addex Therapeutics Ltd
| Revenue | 1.61 M |
| Cost Of Revenue | 6.94 M |
| Gross Profit | -5.32 M |
| Operating Expenses | 11.9 M |
| Operating Income | -10.3 M |
| Other Expenses | 275 K |
| Net Income | -10.6 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||||||||
| Revenue | 1.6 | 1.4 | 2.9 | 3.6 | 2.8 | 6.0 | 0.5 | 17.3 K | 40.3 K | 85.4 K | 91.8 K | 0.1 | 2.8 | 2.0 | 4.1 | 26.8 | 0.5 | 4.7 |
| GROSS PROFIT | ||||||||||||||||||
| Cost Of Revenue | 6.9 | 14.6 | 12.8 | 10.4 | 0.2 | 0.1 | 29.8 K | 17.3 K | 40.3 K | 85.4 K | 91.8 K | 1.3 | 28.0 | 31.2 | 0 | 0 | (0.2) | 0 |
| Gross Profit | (5.3) | (13.2) | (9.9) | (6.8) | 2.5 | 5.9 | 0.5 | 0 | 0 | 0 | 0 | (1.1) | (25.2) | (29.2) | 4.1 | 26.8 | 0.6 | 4.7 |
| OPERATING INCOME | ||||||||||||||||||
| Operating Expenses | 11.9 | 21.9 | 18.4 | 15.9 | 17.4 | 7.5 | 3.2 | 3.1 | 2.6 | 1.8 | 14.5 | 27.0 | 5.8 | 35.6 | 47.6 | 51.7 | 38.1 | 25.8 |
| Selling, General and Administrative Expenses | 7.2 | 7.3 | 5.1 | 5.1 | 4.3 | 4.7 | 2.2 | 1.5 | 1.6 | 1.5 | 6.5 | 12.9 | 6.7 | 6.4 | 7.6 | 7.6 | 10.8 | 0 |
| Research and Development Expenses | 2.7 | 14.7 | 12.8 | 10.4 | 12.5 | 2.4 | 0.8 | 0.8 | 0.8 | 0.3 | 2.2 | 4.8 | 4.8 | 31.2 | 40.0 | 44.2 | 12.2 | 9.8 |
| Operating Income | (10.3) | (20.5) | (15.5) | (12.2) | (14.8) | (1.4) | (3.2) | (3.1) | (3.9) | (1.8) | (14.5) | (27.0) | (31.0) | (33.6) | (43.1) | (24.9) | (37.6) | (20.9) |
| PRE-TAX INCOME | ||||||||||||||||||
| Interest Income Expense | 21.6 K | 48.9 K | 63 K | 69.5 K | 0.1 | 0.2 | 45.4 K | 6.92 K | 0.2 | 0 | 0 | 0 | 0.2 | 0.1 | 0 | 0.5 | 8.54 K | 30.4 K |
| Total Other Income | (0.3) | (0.3) | 0.2 | (0.6) | (0.2) | (0.2) | 45.4 K | 19.8 K | (1.6) | 0.7 | 3.23 K | 8.41 K | (0.2) | 47.6 K | 85.7 | 2.8 | 2.5 | 0.4 |
| Pre-Tax Income | (10.6) | (20.8) | (15.4) | (12.9) | (14.8) | (1.6) | (3.3) | (3.1) | (4.2) | (1.8) | (14.5) | (26.6) | (31.1) | (33.6) | 42.7 | (22.1) | (35.1) | (20.5) |
| NET INCOME | ||||||||||||||||||
| Tax Provision | 0 | 0.1 | 0.1 | 0.2 | 0.4 | 1 | 0 | 6.92 K | 0.2 | 21.7 K | 3.23 K | (0.4) | 72.2 K | 97.3 K | 171.1 | 3.3 | 2.5 | 0.3 |
| Net Income | (10.6) | (20.8) | (15.4) | (12.9) | (14.8) | (1.6) | (3.3) | (3.1) | (4.2) | (1.8) | (14.5) | (26.6) | (31.1) | (33.6) | (42.7) | (22.1) | (35.1) | (20.5) |
| EPS | 0.14 | 0.46 | 0.45 | 0.48 | 0.56 | 0.0706 | 0.25 | 0.28 | 0.39 | 0.18 | 1.6 | 3.36 | 25.1 | 34.1 | 44.7 | 23.1 | 42 | 43.1 |